In late June 2026, Recursion Pharmaceuticals, Inc. was added to multiple Russell value and small-cap benchmarks, including ...

Recursion Pharmaceuticals has been trying to rebuild momentum after a steep five year decline in shareholder returns, yet its ...

Recursion harnesses AI for large-scale drug discovery, while Summit's betting on a single oncology candidate. How do their financials and risk profiles stack up?

Moderna expands beyond vaccines while Recursion bets on AI-driven drug discovery, each with distinct risks, partnerships, and financial profiles.

Vitalik Buterin outlined the updated Lean Ethereum roadmap, a 3-to-4-year plan covering quantum resistance, 10,000 TPS ...

Recursion and Exscientia, two pioneers in artificial intelligence (AI)-based drug development, have completed a business combination that they vowed will enhance their ability to carry out drug ...

Velo3D, Inc. ("Velo3D"), a leading metal additive manufacturing technology company, today announced that Mears Machine Corporation ("Mears") has ordered its fifth Velo3D Sapphire® XC metal additive ...

What happened Security researchers disclosed multiple vulnerabilities affecting Apple AirDrop and Google and Samsung Quick Share that could allow attackers within wireless range to crash or disrupt ...

Nous Research has released Hermes Mixture of Agents 2.0 (MoA 2.0), an update to its open-source Hermes Agent framework that ...

The Council for the Indian School Certificate Examinations (CISCE) has released the ISC Computer Science (Subject Code - 868) for the Year 2027 evaluation cycle. It is designed specifically to make ...

Cathie Wood's ARK Invest purchased $41.2M in Tesla (TSLA) and $2.3M in Bullish while selling $25.3M in Roku shares. See full trade breakdown here.

As organizations race to adopt artificial intelligence, the conversation has increasingly shifted from raw model performance ...